Volume 15, Issue 1, Pages 15-18
Background: Injection sclerotherapy is an established minimally invasive treatment for Grade I and II internal hemorrhoids. This study compared 5% phenol in almond oil with 3% sodium tetradecyl sulphate (STS), focusing on the timing of symptomatic recovery and safety. Subjects and Methods: A prospective interventional study was conducted at TMMC&RC, Moradabad, from June 2024 to December 2025. Sixty patients with Grade I or II internal hemorrhoids were allocated into two groups of 30. Patients received either 5% phenol in almond oil or 3% STS and were assessed at Weeks 1, 3, 6, 12 and 18. Symptomatic recovery was the principal outcome. Results: At Week 1, 19/30 (63.3%) patients in the phenol group had recovered compared with 0/30 in the STS group (p<0.001). By Week 3, 11 of the 12 phenol patients remaining under follow-up had recovered; no STS patient had recovered. STS showed progressive recovery thereafter: 10/30 (33.3%) at Week 6, 9/20 (45%) at Week 12 and 10/11 (90.9%) at Week 18. One STS patient (9.09%) remained unrecovered. No major procedure-related complications were documented. Conclusion: Phenol in almond oil produced a substantially faster early symptomatic response, whereas STS showed a delayed but progressive response. Both agents were well tolerated in this study, and sclerosant selection may be individualized according to the desired speed of symptom relief and feasibility of follow-up.
Hemorrhoids, Injection sclerotherapy, Sodium tetradecyl sulphate, Proctology.
Received 18 January 2026
Revised 01 February 2026
Accepted 19 February 2026
It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0), Creative Commons license that lets people share, remix, and build upon a work, but only for non-commercial purposes and as long as they give credit to the original creator. https://creativecommons.org/licenses/by-nc/4.0/
Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.